Virios Therapeutics (VIRI) Financials

$2.74

$0.37 (15.61%)

As on 10-Dec-2024 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	4.80	5.45	12.32	15.64	10.01	2.18
Operating Profit (EBIT)	-4.80	-5.45	-12.32	-15.64	-10.01	-2.18
Other Income	--	--	--	--	--	--
Profit before Tax	-4.68	-5.30	-12.25	-15.96	-10.35	-2.47
Provision for Tax	-1.27	-0.01	-0.07	0.32	-0.04	0.30
Profit after Tax (Net Income)	-4.68	-5.30	-12.18	-15.96	-10.35	-2.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-12.25	-15.96	-10.35	-2.47

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	3.14	3.81	7.33	14.50	29.94	-4.94
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.57	0.35	0.37	3.64
Current Liabilities	0.50	0.36	1.04	1.28	1.53	1.62
Total Liabilities	4.14	4.17	8.37	15.78	31.47	0.32

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	--	--	--	--	--	--
Current Assets	3.64	4.17	8.37	15.78	31.47	0.32
Total Assets	4.14	4.17	8.37	15.78	31.47	0.32
Total Debt*	--	--	--	--	--	3.64
Net Current Assets	3.14	3.81	7.33	14.50	29.94	-1.30

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-4.87	-11.47	-15.69	-3.90	-2.09
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	1.16	4.49	-0.10	33.38	2.37
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-95.14	-111.61	-71.83	-72.26	215.86
ROE (%)	-134.80	-95.14	-111.61	-71.83	-82.78	89.27
ROA (%)	-101.22	-84.50	-100.89	-67.56	-65.09	-1,450.24
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	6.97	57.00	21.26	-56.33	-359.28	-11.06
Net Profit Growth (%)	37.45	56.52	23.68	-54.26	-273.68	-31.00
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	3.33	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.22	-21.98	0.57	0.90	2.98	--
Close Price ($)	5.38	14.38	5.90	127.88	187.75	--
High Price ($)	60.50	60.50	227.77	233.00	417.75	--
Low Price ($)	3.89	5.55	5.48	100.00	180.25	--
Market Cap ($ Cr)	0.21	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	--	--	--	--	-0.74
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	7.27	11.62	8.02	12.37	20.55	0.19
Quick Ratio	7.27	--	--	--	20.55	0.20
Interest Coverage	-114.76	--	-182.52	-2,757.57	-26.04	-7.38

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.